Eytan de Gunzburg
Lawyers
Filters
Nova Biomedical $2.2 billion acquisition by Advanced Instruments
We are advising Nova Biomedical on the transaction
Bacardi $1 billion notes offering
The investment-grade notes are due 2030 and 2035
GHK Capital Partners completes $870 million fundraise for its second fund
We advised GHK Capital Partners on the fundraise and related matters for GHK Fund II
Jazz Pharmaceuticals $1 billion exchangeable senior notes offering
The exchangeable notes are due 2030
Flex $500 million notes offering
The investment-grade notes are due 2032
Applied Materials $700 million senior notes offering
The investment-grade notes are due 2029
ConvergeOne prepackaged chapter 11 filing and restructuring support agreement
We are advising an ad hoc group of second-lien lenders in connection with ConvergeOne’s chapter 11 proceedings